Location: Stockholm, Sweden
CIK: 0001381843 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Jul 8, 2022
Total Value: $43.38M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UTMD | UTAH MED PRODS INC | 86,000 | $7.387M | 17.0% | $87.95 | -3.0% | COM | 917488108 |
| — | LA JOLLA PHARMACEUTICAL CO | 1,265,000 | $4.035M | 9.3% | $3.89 | — | COM | 503459604 |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 76,000 | $3.707M | 8.5% | $32.59 | +38.1% | COM | 413197104 |
| CI | CIGNA CORP NEW | 14,000 | $3.689M | 8.5% | $218.34 | +10.6% | COM | 125523100 |
| GILD | GILEAD SCIENCES INC | 58,000 | $3.585M | 8.3% | $55.16 | -1.9% | COM | 375558103 |
| BMY | BRISTOL-MYERS SQUIBB CO | 44,000 | $3.388M | 7.8% | $49.60 | +31.0% | COM | 110122108 |
| BIIB | BIOGEN INC | 16,000 | $3.263M | 7.5% | $217.46 | -6.0% | COM | 09062X103 |
| MCK | MCKESSON CORP | 10,000 | $3.262M | 7.5% | $203.36 | +54.5% | COM | 58155Q103 |
| VTRS | VIATRIS INC | 310,000 | $3.246M | 7.5% | $9.29 | 0.0% | COM | 92556V106 |
| ZVRA | KEMPHARM INC | 670,000 | $2.988M | 6.9% | $5.25 | -13.1% | COM NEW | 488445206 |
| — | OPIANT PHARMACEUTICALS INC | 210,000 | $2.518M | 5.8% | $12.80 | — | COM | 683750103 |
| AUPH | AURINIA PHARMACEUTICALS INC | 230,000 | $2.312M | 5.3% | $11.18 | 0.0% | COM | 05156V102 |